Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of Loratadine for Prevention of Pegfilgrastim-Induced Pain
This study is currently recruiting participants.
Verified January 2013 by University of Vermont
Study NCT01311336   Information provided by University of Vermont

First Received on March 8, 2011.   Last Updated on January 23, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Interventions listed in this trial
Loratadine
placebo
Additional drug interventions recognized in this trial
Lenograstim
More general drug interventions related to this trial
Adjuvants, Immunologic
Anti-Allergic Agents
Antipruritics
Dermatologic Agents
Histamine Agents
Histamine Antagonists
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Immunologic Factors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
University of Vermont
Cancer and Leukemia Group B


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services